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1. Introduction 
Somatic sensations of the head and orofacial region are transmitted by trigeminal primary 
afferent neurons, a group of neural-crest derived sensory neurons. Most of their cell bodies 
are located outside the central nervous system, residing in the trigeminal ganglion (TG) but 
some of them lie centrally within the brainstem, in the mesencephalic trigeminal nucleus 
(MTN). 
The TG represents a cranial analog of the dorsal root ganglia in the peripheral nervous 
system (Darian-Smith, 1973). TG neurons have a unique morphology and are classified as 
pseudounipolar (Krastev, 2009). Their centripetal processes, usually called trigeminal 
primary afferents, carry somatosensory information from mechanoreceptors, 
thermoreceptors and nociceptors in the face, the oral and nasal cavities, and through the 
portio major of the trigeminal nerve reach their main target neurons in the trigeminal 
sensory nuclei (Fig. 1), where they establish synaptic contacts with their perikarya (for 
reviews, see Darian-Smith, 1973; Dubner et al., 1978; Kruger & Young, 1981). 
Mesencephalic trigeminal neurons are considered centrally displaced ganglion cells but in 
spite of their curious central location they maintain some characteristics of neural crest 
cell derivates. The great majority of MTN cells are large pseudounipolar neurons which 
provide the innervation of the masticatory muscle spindles and periodontal ligament 
pressoreceptors. Their central branches enter the trigeminal motor nucleus and several 
other brainstem nuclei around it (Fig. 1), where they make excitatory synaptic connections 
with jaw-closing motor or premotor (last-order interneurons) neurons, respectively (see 
Capra & Dessem, 1992 for a review). Unlike the TG cells however, MTN neurons receive 
synaptic inputs that potentially modify their output (reviewed in Lazarov, 2000). MTN 
neurons are also remarkable insofar as they, without an exception, constitute one distinct 
functional class of trigeminal sensory neurons, i.e. proprioceptive neurons (Jerge, 1963; 
Cody et al., 1972). Due to their ectopic location within the brain, in addition to this 
classical function, some mesencephalic trigeminal neurons may act as interneurons 
capable of integrating peripheral and central information prior to reaching the trigeminal 
motor nucleus (Kolta et al., 1995). The functional segregation between peripheral and 
central primary afferent neurons is a further striking feature of the mammalian trigeminal 
sensory system (reviewed in Waite, 2004). 
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Fig. 1. Schematic illustration of the trigeminal pathways for orofacial somatic sensation. 
Tactile (touch and pressure) sensibility of the face and mouth is relayed through the large 
diameter Aǃ axons of the trigeminal ganglion (TG) neurons to the principal sensory 
trigeminal nucleus (PrTN) and rostral part (subnucleus oralis and interpolaris) of the spinal 
trigeminal nucleus (SpTN), while pain and thermal sensations from the orofacial structures 
are conveyed by the thin A and C trigeminal primary afferents to the subnucleus caudalis 
of the SpTN. Proprioceptive sensation from the face and oral cavity is transmitted directly or 
through premotor neurons in the supratrigeminal nucleus (SuTN) to the motor trigeminal 
nucleus (MoTN) via the central processes of primary afferent neurons whose 
pseudounipolar cell bodies are mainly located in the mesencephalic trigeminal nucleus 
(MTN). The efferent limb (depicted in red) of the reflex arc producing jaw closure (jaw jerk 
or masseteric reflex) is formed by the axons of trigeminal motoneurons traveling through 
the motor root of the trigeminal nerve to the muscles of mastication. V1, V2, V3, ophthalmic, 
maxillary and mandibular divisions of the trigeminal nerve, respectively.  
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A commonly held hypothesis in neurobiology is that neuronal morphology frequently 
mirrors chemical neuroanatomy and also neurons in different functional pathways, within 
which they lie, can be characterized by their neurochemical profiles. In this respect, the 
various neuronal populations that constitute the TG and MTN can be identified not only on 
the basis of their morphological characteristics and electrophysiological properties but also 
by their neurochemical content. This issue is of key importance since the transmitter content 
of different neuronal populations often correlates well with their target projections. It is 
assumed that trigeminal primary afferent neurons exhibit pathway-specific patterns of 
neurochemical expression, a concept that has been called chemical coding (Costa et al., 
1986). It has also been proposed that the differently fated embryonic migration, 
synaptogenesis, and peripheral and central target field innervation could affect the 
individual neurochemical phenotype of TG and MTN neurons. Trigeminal primary afferent 
neurons utilize a wide variety of chemical neuromessengers for synaptic transmission and 
possess the ability to produce relevant adaptive changes in their neurochemical phenotype 
in response to environmental cues (for recent reviews, see Lazarov, 2002, 2007).  
This chapter therefore focuses on the chemical neuroanatomy of the TG and MTN neuronal 
populations under normal conditions, the role and relationship of neurotransmitters and 
their corresponding receptors in relaying orofacial sensations and also refers to the 
interactions with other atypical neuromessengers and neurotrophic factors. We have also 
surveyed the chemical plasticity of developing and mature TG and MTN neurons to gain 
insight into their structural and functional properties in an altered neurochemical balance, 
with special reference to trigeminal nerve degeneration and regeneration, and clinical 
implications. 
2. Neurotransmitters and their known receptors in trigeminal primary afferent 
neurons 
Using immunohistochemistry and in situ hybridization histochemistry we have identified 
distinct neuronal, partly chemically coded, subpopulations in the intact TG and MTN. Our 
findings suggest that trigeminal primary afferent neurons are chemically heterogeneous and 
appear to use various chemical neuromediator candidates for synaptic transmitters. These 
include classical and peptide transmitters, calcium-binding proteins as neuronal markers 
and other neuroactive molecules (Table 1). In addition, we have demonstrated that TG and 
MTN neurons receive inputs from different groups of neurons that contain multiple 
transmitter substances. Indeed, both the TG and MTN receive catecholaminergic, nitrergic 
and peptidergic innervation in the form of perineuronal arborizations encircling in a basket-
like manner the perikarya of large unstained neurons. It is assumed that the pericellular 
baskets can function as a key communication medium between immunopositive projections 
and immunonegative neuronal somata in the orofacial somatosensory information 
processing. Last but not least, it is now well established that the cell bodies of TG and MTN 
neurons are richly endowed with postsynaptic receptors for a huge array of 
neurotransmitters and neuroactive substances. 
2.1 Classical transmitters 
In recent years, a variety of ‘classical’ transmitter substances and their receptors have been 
associated with subsets of trigeminal primary afferent neurons. Among them are amino 
acids (both excitatory and inhibitory) and monoamines. On the other hand, our studies  
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Neuroactive substance Trigeminal ganglion 
Mesencephalic 
trigeminal nucleus 
Effect of activation 
Neurotransmitters and 
their known receptors 
   
Glutamate (GLU) + +IC, F/T 
Membrane 
depolarization: fast 
and/or slow excitation 
AMPA receptors - +IC 
Postsynaptic rapid 
excitation 
KA receptors + +IC 
Presynaptic 
modulation of 
transmitter release 
NMDA receptors - +IC 
Presynaptic auto- or 
postsynaptic 
heteroreceptors 
metabotropic receptors mGluR5 mGluR1ǂ, mGluR2/3 
Heteroreceptors and/or 
autoreceptors: 
neuronal excitability 
and transmission 
regulation 
Aspartate + ±IC, F/T 
Membrane 
depolarization 
Gamma aminobutyric 
acid (GABA) 
+ ±IC, F/T 
Membrane 
hyperpolarization: 
inhibition Membrane 
depolarization: 
excitation 
GABAA receptor + (Ǆ1, Ǆ2 subunits) +IC Postsynaptic fast 
inhibition 
GABAB receptor + (GABAB2 subunit) +IC 
Presynaptic regulation 
of K+, Ca2+channels: 
long-term inhibition of 
synaptic transmission 
Postsynaptic 
facilitation of ATP, 
SER and DA release 
Glycine - -  
Dopamine (DA) - +F/T 
Membrane 
hyperpolarization  
D1 receptor - +IC 
Masseter muscle 
proprioceptive 
processing 
D2 receptor + +P 
Periodontal ligament 
proprioceptive 
processing 
Serotonin (SER) - +F/T 
Membrane 
depolarization: 
modulation of sodium 
currents 
5-HT1B receptor + ND  
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Neuroactive substance Trigeminal ganglion 
Mesencephalic 
trigeminal nucleus 
Effect of activation 
5-HT1D receptor + ND  
5-HT1F receptor + ND  
5-HT2 receptor ND +IC 
Intracellular 
transduction pathways 
activation 
5-HT3 receptor ND +IC 
Postsynaptic slow 
excitation 
5-HT7 receptor + ND  
Histamine (HIS) ND +F/T 
Membrane 
depolarization 
H1 receptor + +IC Postsynaptic excitation 
H3 receptor - +P Presynaptic inhibition 
Adenosine 5I-
triphosphate (ATP) 
ND +F/T 
Membrane 
depolarization 
Facilitation of neuronal 
discharge 
P2X2 receptor + + 
Postsynaptic fast 
excitation 
P2X3 receptor - + 
Presynaptic 
modulation of 
P2X4 receptor + + 
neurotransmitter 
release 
P2X5 receptor + +  
P2X6 receptor + +  
P2Y receptor - -  
Nitric oxide (NO) + +IC 
Membrane 
depolarization: 
promotion of 
intracellular cGMP 
synthesis; 
Carbon monoxide (CO) 
Neuropeptides and their 
known receptors 
+ + 
tonic background 
stimulation 
Substance P (SP) + - Neuromodulation 
SP receptor - - Neuromodulation 
SOM ss2(b) receptor - +  
Neuropeptide Y (NPY) + -  
NPY Y1 receptor + -  
NPY Y2 receptor + -  
NPY Y5 receptor - +  
Enkephalin (ENK) + - Neuromodulation  
Preprodynorphin + ND  
µ-opioid receptor + -  
-opioid receptor + -  
κ-opioid receptor + -  
Orexin (hypocretin) A - +F/T Neuromodulation 
Orexin receptor-1 ND + 
Induction of calcium 
currents 
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Neuroactive substance Trigeminal ganglion 
Mesencephalic 
trigeminal nucleus 
Effect of activation 
Orexin (hypocretin) B - +F/T Neuromodulation 
Orexin receptor-2 ND + 
Induction of calcium 
currents 
Calcium-binding 
proteins 
   
Parvalbumin (PV) + +IC 
Intracellular Ca 
buffering 
   
Selective marker for 
orofacial 
proprioceptors 
Calbindin D-28 (CB) + +IC 
Selective neuronal 
marker 
Calretinin (CR) + +IC NA 
S-100 + - Selective glial marker 
Neurocalcin + -  
Osteocalcin + +IC Selective marker 
Osteopontin + +IC Selective marker 
Peptide 19 + +IC Selective marker 
Nerotrophic factors and 
their receptors 
   
Pan-neurotrophin  
receptor P75NTR 
+ +IC 
Increase in mature 
neuronal excitability 
Nerve growth factor 
(NGF) 
+ +IC,F Trophic support 
TrkA + +IC NA 
Brain derived 
neurotrophin factor 
(BDNF) 
+ +IC 
Trophic support 
Neuronal phenotype 
maintenance 
Neurotrophin 4-5 (NT-
4/5) 
+ - NA 
TrkB + +IC Neuronal survival 
Neurotrophin 3 (NT-3) + +IC Trophic support  
   
Modulation of 
neuronal electric 
activity 
TrkC + +IC Neuronal survival 
Glial cell line-derived 
neurotrophic factor 
(GDNF) 
  Trophic support 
GFRalpha-1 receptor + +IC NA 
Ret receptor + +IC NA 
IC, intracellular; F/T, fibers and/or terminals; ND, no data; NA, not analyzed; P, pontine portion of 
MTN 
 
Table 1. Overview of the established and putative neuromessengers, specific markers, 
neurotrophic factors and their known receptors and major functions in orofacial 
somatosensory signaling under normal conditions 
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clearly show that other classical neurotransmitters, such as acetylcholine, and purines like 
adenosine 5I-triphosphate (ATP) and its metabolite adenosine are not present in TG and 
MTN neurons. 
2.1.1 Amino acids 
There are three major amino acid neurotransmitters in the nervous system: glutamic acid (L-
glutamate), gamma-amino butyric acid (GABA) and glycine. Glutamate (Glu) is considered 
a promising excitatory transmitter of the trigeminal primary afferent neurons in rats and 
cats. It is stored in both the large and small TG cells (Wanaka et al., 1987; Azérad et al., 1992; 
Stoyanova et al., 1998), and, in addition, all five known kainate (KA) ionotropic receptor 
subtypes are expressed in a majority of them, occasionally combined with metabotropic 
mGluR5 subunits (Sahara et al., 1997). Experimental results indicate that the metabotropic 
Glu receptors play an important role in the somatic sensation of TG neurons together with 
the ionotropic ones (Araki et al., 1993). Functional contribution of peripherally localized Glu 
receptors in acute and chronic pain processing is amply documented (Carlton, 2001) and 
further discussed in Section 5. Similarly, most mammalian MTN neurons contain 
glutaminase, a major enzyme involved in the biosynthesis of Glu (Kaneko et al., 1989; 
Turman & Chandler, 1994b) and receive glutamatergic synaptic input (Chandler, 1989; 
Copray et al., 1990). Further, recent research has revealed that vesicular glutamate 
transporter 1 is expressed in the cell bodies as well as both in the central axon terminals and 
peripheral sensory endings of MTN neurons in newborn and adult rats (Pang et al., 2006). 
Finally, all ionotropic receptor subtypes, AMPA (Mineff et al., 1998; Pelkey & Marshall, 
1998; Petralia & Wenthold, 1992; Turman et al., 2000), KA and NMDA (Pelkey & Marshall, 
1998; Petralia et al., 1994a,b,c; Turman et al., 2002) and some metabotropic subtypes, 
mGluR1ǂ, mGluR5 and mGluR2/3 (Turman et al., 2001) have been localized on 
mesencephalic trigeminal neurons. Iontophoretic studies have also suggested that 
monosynaptic transmission between jaw-closing primary afferents and jaw-closing 
motoneurons is mediated primarily by non-NMDA receptors (Chandler, 1989), whereas 
both NMDA and non-NMDA receptors have been involved in the transmission from 
premotoneurons to jaw-opening motoneurons (Katakura & Chandler, 1990). The 
identification of mGluR subunits in mesencephalic trigeminal neurons which receive, as 
already noted, axosomatic input and/or synthesize mGluRs in the soma and then 
translocate the proteins to central terminals suggests that these, along with NMDA but not 
AMPA receptors, may function as either auto- or heteroreceptors in central MTN terminals 
(Turman et al., 2001). 
GABA and glycine are both known to participate in the control of masticatory rhythms 
(Chandler et al., 1985). The presence of glycine, however, has been reported neither in TG 
nor in MTN neurons (Copray et al., 1990; Lazarov, 2002). On the other hand, GABA is 
localized in a substantial number of TG cells in rats (Szabat et al., 1992) and cats (Stoyanova 
et al., 1998). In addition, TG cells express two distinct GABA receptors, ionotropic GABAA 
Ǆ1 and Ǆ2 subunits, mostly co-localized in the same neuron (Kondo et al., 1994), and 
metabotropic GABAB2 (Durkin et al., 1999). Our experiments have also pointed out that a 
subpopulation of smaller MTN cells, presumably interneurons, which are apposed to large 
mesencephalic trigeminal neurons, may be of a GABAergic nature (Lazarov & Chouchkov, 
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1995b; Lazarov, 2000, 2002). Besides, molecular biological studies have shown that 
pseudounipolar MTN neurons respond to GABA and accordingly express GABAA receptor 
ǂ2, ǃ2 and Ǆ2 subunit mRNAs (Hayar et al., 1997; Ishii & Kang, 2002), and GABAB1 
(Margeta-Mitrovic et al., 1999) and GABAB2 (Li et al., 2001) receptor proteins. In line with 
this evidence, several research groups have consequently reported GABAergic innervation 
of the MTN in rats (Copray et al., 1990; Ginestal & Matute, 1993), guinea pigs (Turman & 
Chandler, 1994a), rabbits (Kolta et al., 1991a,b) and cats (Lazarov & Chouchkov, 1995b; 
Lazarov, 2000, 2002). Ultrastructural and confocal laser-scanning studies have additionally 
revealed the existence of GABAergic synapses upon the cell bodies of MTN neurons in the 
rat (Chen et al., 2001). Taken together, these results suggest that excitability of jaw muscle 
spindle afferents is presynaptically controlled by interneurons containing GABA and these 
play an important role in modulating the jaw-jerk reflex. 
Our findings now permit definitive conclusions that both TG and MTN neurons contain a 
stable concentration of Glu and GABA as possible transmitters. It still remains to clarify the 
possible synaptic relationships between Glu- and GABA-immunoreactive profiles in the TG 
and MTN, and their related functional implications. We have observed that both amino acid 
neurotransmitters are present in separate subpopulations of trigeminal neurons, e.g. most 
large neurons are glutamatergic while certain small neurons are GABAergic (Lazarov, 2002). 
Thus, it seems likely that excitatory amino acid(s) may be the transmitter(s) of large 
myelinated non-nociceptive primary afferents whereas GABA is probably the mediator of 
smaller trigeminal neurons, as suggested by Salt & Hill (1983).  
2.1.2 Monoamines 
Out of the six different types of monoamines, catecholamines [dopamine (DA), 
noradrenaline (NA) and adrenaline (A)] are the most important group. The earliest evidence 
for the catecholaminergic innervation of the TG sprang from the works of Santini (1966) and 
Lukás et al. (1970). In these initial studies by using immunocytochemistry with antiserum 
against tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine synthesis, the 
immunostained neurons within the ganglion were proposed to be DAergic. Applying an 
antibody against the DA molecule itself, it is now inferred that TH-containing neurons in the 
TG do not synthesize DA but they are enveloped by DAergic pericellular arborizations 
(Kummer et al., 1990). A similar pattern has been observed for NA within the ganglion: TG 
cells are immunonegative to the NA-synthesizing enzyme, dopamine-ǃ-hydroxylase (Katz 
et al., 1983) but receive dense NAergic innervation from postganglionic sympathetic 
neurons (Kummer et al., 1990). Hence, immunohistochemical evidence has suggested that 
TG neurons do not utilize catecholamines as possible transmitters but are under the 
influence of catecholaminergic afferent fibers of presumable sympathetic origin. Clinical 
observations imply that primary afferent neurons whose cell bodies reside in the TG express 
receptors for DA of the D2 subtype, although these receptors do not function as 
autoreceptors but rather have a role in pain syndromes involving the head and the neck 
(Peterfreund et al., 1995).  
In the same way, none of the MTN neurons in rats (Copray et al., 1990; Liem et al., 1997), 
cats (Lazarov & Chouchkov, 1995b) and humans (Usunoff et al., 1997) exhibits 
immunoreactivity for DA or NA but their perikarya are closely surrounded by fine DAergic 
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and NAergic baskets originating from the A9 and A10 cell groups, the substantia nigra and 
ventral tegmental area, and the neighboring locus coeruleus, respectively. Our 
immunohistochemical and in situ hybridization experiments have further shown that MTN 
neurons express the two principal subtypes of DA receptors, though they are unequally 
distributed within the nucleus: as in muscle spindle afferents, D1 receptors are found 
throughout the MTN of the rat, whereas D2 receptors and periodontal afferent neurons are 
confined to the caudal part of the nucleus (Lazarov & Pilgrim, 1997). This suggests that the 
two types of primary afferents may be modulated differentially by DA. The DA input to the 
MTN may modulate neuronal excitability, rates of transmitter synthesis, transport and 
release, as well as the number of pre- and postsynaptic receptors (Liem et al., 1997). 
In addition to the catecholaminergic input, the TG and MTN are under the influence of 
another monoaminergic system, namely the serotoninergic system, one of the oldest amine 
systems in the brain. Indeed, several immunohistochemical studies have revealed the 
serotoninergic supply of the mammalian TG and MTN. In fact, we have found that the TG 
lacks intrinsic serotonin (SER)-containing cells but a plexus of varicose nerve fibers of 
extraganglionic origin covers the immunonegative neurons in a basket-like manner 
(Chouchkov et al., 1988). Likewise, SER is present neither in the cell bodies nor in neuronal 
processes of MTN neurons (Lazarov & Chouchkov, 1995a). However, SERergic axonal 
varicosities reaching the MTN from the mesopontine and medullary raphe nuclei form a 
pericellular basket-like network around immunonegative mesencephalic trigeminal neurons 
(Tashiro et al., 1989). Electron microscopic studies show direct synaptic contacts between 
SER-containing terminals and MTN perikarya in rats (Copray et al., 1991; Liem et al., 1993; 
Liem & Copray, 1996; Li et al., 2000), cats (Lazarov & Chouchkov, 1995a) and rabbits (Kolta 
et al., 1993). Out of the large group of the serotonin receptors, also known as 5-
hydroxytryptamine receptors or 5-HT receptors, the presence of high affinity 5-HT1B and 5-
HT1D receptors is demonstrated at protein and mRNA levels in TG neurons of the rat 
(Bruinvels et al., 1992; Wotherspoon & Priestley, 2000), guinea pig (Bonaventure et al., 1998) 
and human (Longmore et al., 1997). The mRNA encoding the 5-HT7 receptor is also found to 
be expressed in the human TG (Terrón et al., 2001). At the same time, in the rat MTN an 
abundant number of the 5-HT2 (Cornea-Hébert et al., 1999), 5-HT3 (Morales et al., 1998) and 
5-HT4 receptor (Lazarov, 2007) have been established. SER has been hypothesized to be 
involved in trigeminal pain (Moskowitz et al., 1979) and SER antagonists have important 
clinical implications for antimigraine drug development (discussed later in Section 5). 
Recent data indicate that SER plays a significant role in the control of oral-motor activity as 
well (Li et al., 2000) and various oral-motor disorders, either drug induced or occurring as a 
consequence of injury, might result from altered modulation of sodium channels by SER 
(Tanaka & Chandler, 2006). 
As in the case of catecholamines, both peripheral and central trigeminal primary afferent 
neurons do not contain histamine in their cell bodies but MTN neuronal perikarya receive a 
direct histaminergic input by hypothalamic descending fibers (Inagaki et al., 1987). In 
particular, neuronal somata throughout the whole rostrocaudal length of the nucleus are 
encircled by histaminergic fibers and their terminals, many of the latter forming axo-somatic 
synapses on them. Our laboratory has provided immunohistochemical evidence for the 
presence of two distinct histamine receptor subtypes, H1 and H3, in the rat MTN, albeit in 
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different neuronal subpopulations (Lazarov & Gratzl, 2006). Overlapping with muscle 
spindle afferents, histamine H1 receptors are scattered throughout the full extent of the 
MTN, whereas H3 receptors and periodontal afferent neurons are restricted to its caudal 
region. Since H1 receptors are excitatory, histamine may act in this way on MTN neurons via 
the axo-somatic synapses, as suggested by Inagaki et al. (1987). Conversely, the H3 receptors 
do not function only as autoreceptors but also as heteroreceptors, modulating MTN 
neuronal activity and release of other neurotransmitters from them. Therefore, it seems that 
the majority of MTN neurons respond to central histamine via the activation of H1 and 
inhibition of H3 receptors, thus participating in the control of feeding behavior. 
The purine nucleosides adenosine and ATP can function as neurotransmitters or 
neuromodulators in both the CNS and PNS by signaling through specific receptors 
termed adenosine (also known as P1) and P2 receptors, respectively. Our attempts fail to 
identify purines in the TG and MTN neurons, though the latter are innervated by 
adenosine deaminase-containing projections from the hypothalamus (Nagy et al., 1986). 
Inasmuch as their terminals contacting MTN perikarya also express immunoreactivity to 
histamine, it seems that the two substances may coexist there, as noted by Yamamoto et 
al. (1988). In the TG, an abundant expression of the adenosine A1 receptor protein 
(Schindler et al., 2001) and the six P2X receptor subtypes (Xiang et al., 1998; Dunn et al., 
2001) has been shown in a large number of small nociceptive neurons, which may be 
suggestive of a role of these receptors in analgesia. The existence of excitatory adenosine 
A2A receptors (Rosin et al., 1998) and P2X2, P2X3, P2X4, P2X5 and P2X6 purinoceptors 
(Khakh et al., 1997; Patel et al., 2001; Lazarov, 2007) has been shown in populations of 
large proprioceptive mesencephalic trigeminal neurons. P2X receptors, which are ATP-
gated cation channels, have been shown to be responsible for mediating both fast 
excitatory responses in central and peripheral neurons and the presynaptic modulation of 
neurotransmitter release (reviewed by Ralevic & Burnstock, 1998). It is likely that certain 
ionotropic P2X purinoceptors may be involved in the processing of proprioceptive 
information, thus suggesting a potentially important physiological role of ATP at sites 
where it is released extracellularly (Khakh et al., 1997). 
2.2 Neuropeptides 
Neuropeptides are a heterogeneous group of several hundred biologically active peptides, 
present in neurons of both the mammalian CNS and PNS, and involved in the transmission 
of signals as pure neuromediators or neuromodulators. In general, a large number of 
putative peptide transmitters have been identified in neurons and/or neuronal processes in 
the TG, but none of them has been found in mammalian MTN neuronal somata under 
normal conditions (see reviews by Lazarov, 1994, 2002, 2007). In particular, two 
subpopulations of primary afferent neurons, containing neuroactive peptides are 
distinguished in the TG: a number of substance P (SP)-, neurokinin A (NKA)-, calcitonin 
gene-related peptide (CGRP)-, cholecystokinin (CCK)-, somatostatin (SOM)-, vasoactive 
intestinal polypeptide (VIP)- and galanin (GAL)-immunoreactive ganglion cells with small- 
and medium-sized somata, and relatively fewer in number larger-sized neuropeptide Y 
(NPY)- and peptide 19 (PEP 19)-immunoreactive trigeminal neurons. It is noteworthy that 
SP, CGRP, SOM and GAL are found in small-diameter TG cells with conduction velocities in 
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the C-fiber range, PEP 19 and NPY are usually expressed in the large ones, and opioid 
peptides, CCK, VIP and pituitary adenylate cyclase activating polypeptide (PACAP) are 
observed in both small and large trigeminal neurons (Kummer & Heym, 1986; Weihe, 1990). 
Our previous studies have also revealed that although devoid of synaptic contacts, TG 
neurons express an array of peptide receptors for SP, CGRP, CCK, opioid peptides and NPY 
(see Lazarov, 2002, and references therein). The occurrence of peptidergic arborizations of 
extrinsic origin around the perikarya of some TG neurons suggests that these are under the 
influence of multiple biologically active peptides. 
Several lines of physiological evidence indicate that SP and CGRP have excitatory effects 
and depolarize TG neurons (Otsuka & Konishi, 1976; Spigelman & Puil, 1991) while SOM 
and opioids appear to be inhibitory in nature (Randic & Miletic, 1978). Considering the 
important functional segregation of TG cells into large (mostly mechanoreceptive) and small 
(mainly nociceptive) neurons, it is not surprising that the neuropeptides SP and CGRP have 
been associated with the transmission of nociceptive impulses. However, small-diameter 
primary afferent neurons not only transmit noxious messages to central neurons but are also 
active in the periphery in mediating axon-reflex mechanisms and an inflammation response 
(Couture & Cuello, 1984; Foreman, 1987). Therefore, it is more reasonable to consider the 
role of SP and CGRP both in the transmission of sensory information from the periphery 
and in the peripheral effector functions such as neurogenic vasodilatation (McCarthy & 
Lawson, 1989, 1990), thus implicating them into the pathophysiology of migraine. Moreover, 
SOM can interact with SP causing inhibition of its release and consequent neurogenic 
vasodilatation (Brodin et al., 1981). Several lines of evidence indicate that sensory opioids 
could act synergistically with SP to induce histamine release (Foreman, 1987) and GAL may 
have an inhibitory effect on the nociceptive transmission (see Xu et al., 1990, and references 
therein). Therefore, all these peptides play a co-transmitter role and may have significant 
functions in disease mechanisms associated with head pain in humans (for a recent review, 
see Edvinsson & Uddman, 2005). 
In view of the presence of a large number of neuropeptides in the TG cells, their absence in 
the morphologically homologous MTN neurons is rather surprising. Obviously, the absence 
of a peptide in two distinct populations of trigeminal primary afferent neurons indicates 
that different peptides subserve diverse sensory modalities, at least under normal 
conditions. In extension of previous inferences, we are confident that there exists a complex 
coexistent relationship between the chemoanatomical constellation of trigeminal primary 
afferent neurons and sensory modality transmission (Lazarov, 2002). Notwithstanding that 
intact mesencephalic trigeminal neurons do not express neuropeptides in their perikarya 
they are largely influenced by various synaptic inputs. Relevant to the dense peptidergic 
innervation of the nucleus, receptors for certain peptides have been localized on MTN 
neuronal somata (reviewed in Lazarov, 2002, 2007). According to Copray et al. (1990) it is 
likely that the synaptic input on MTN cells only affects the neuronal activity expressed at 
the central and peripheral terminals, in a more indirect mode and after a longer interval. The 
authors claim that this points to the presence and involvement of receptor systems that are 
not directly linked to ion channels but to a much slower secondary-messenger-induced 
biochemical effector cascade. As argued in the Introduction section, MTN neurons may 
operate under some circumstances like traditional “integrate and fire” neurons in addition 
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to typically sensory neurons, which generally do not receive synaptic contacts at their 
somata and do not discharge repetitively (Del Negro & Chandler, 1997).  
2.3 Gaseous neuromessengers 
In addition to the classical and peptide transmitters, several second messenger systems may 
be involved in orofacial signal processing. During the last decade the free radical gases nitric 
oxide (NO) and carbon monoxide (CO) have been found to function as putative messenger 
molecules both in central and peripheral trigeminal primary afferent neurons. Indeed, 
recent research in animals and humans has shown that the neurons in the MTN, along with 
TG cells, contain heme oxygenase, the CO-synthesizing enzyme (Uddman et al., 2004; Fan et 
al., 2008). The enzyme responsible for the synthesis of NO, nitric oxide synthase (NOS), and 
its histochemical marker, NADPH-diaphorase are expressed both in TG and MTN neurons 
in rats (Stoyanova & Lazarov, 2005), rabbits (Kolesar et al., 2006) and cats (Lazarov & 
Dandov, 1998) as well. The nerve cell bodies containing NOS are predominantly of small to 
medium size and they also express SP and CGRP (Edvinsson et al., 1998). Moreover, all 
these studies demonstrate that large unstained trigeminal neurons are innervated by 
nitrergic fibers and that NO increases the excitability and modifies other 
electrophysiological properties of these cells. Rather than acting via traditional receptors on 
the postsynaptic membrane, NO exerts its effect by diffusion into the adjacent neurons to 
activate soluble guanylyl cyclase, leading to an increase in intracellular cGMP. Furthermore, 
NO possibly produces an increase in MTN neuronal electrotonic coupling and therefore is 
involved in the synchronization of their activity too. Finally, there is functional evidence to 
support the involvement of NO in the development and maintenance of inflammation and 
pain (Yun et al., 1996). It has been suggested that as in other regions, both gaseous 
messengers possibly interact in a complex, dynamic way in the orofacial sensory processing 
where CO, being a more stable gas, may be responsible for basal activity and provide tonic 
background stimulation, whereas surges of NO transiently amplify or deliver phasic 
signaling (Fan et al., 2008). 
2.4 Calcium-binding proteins 
The calcium-binding proteins (CaBPs) represent one of the physiological systems for 
maintaining calcium ion intracellular homeostasis (reviewed in Baimbridge et al., 1992). In 
the last two decades they have received increased attention due to their implementation as 
specific markers for large-sized primary afferent subpopulations and their involvement in 
many calcium-dependent phenomena in the nervous system both under normal and 
abnormal conditions (Anderssen et al., 1993). Neuron-specific CaBPs, parvalbumin (PV), 
calbindin D-28k (CB) and calretinin (CR), are observed to be expressed predominantly in the 
large-sized TG and MTN neurons (Ichikawa et al., 1994; Lazarov et al., 1998), a 
subpopulation with inward calcium current. Interestingly, a typical glial cell-specific 
protein, S-100, is also localized, mostly co-expressed with CB, in TG neurons of epibranchial 
placode origin (Ichikawa et al., 1997). In addition, immunoreactivity to neurocalcin, a newly 
identified member of the neuronal CaBP family, has been shown in large or medium in size 
TG cells (Iino et al., 1998). Two additional newly discovered bone matrix CaBPs, osteocalcin 
and osteopontin, have recently been co-localized with PV in the cell bodies of both TG and 
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MTN neurons (Ichikawa et al., 1999; 2000). Data from ongoing experiments have provided 
compelling evidence that CaBPs might function as intracellular calcium transporters or as a 
buffering system for cell protection during neuronal activity in normal circumstances. They 
may also affect calcium-dependent neuronal properties such as excitability, release of 
neurotransmitters and resistance to excitotoxicity in mammals (see Baimbridge et al., 1992). 
Additionally to intracellular roles, S-100 may be involved in the neurotrophic functions of 
trigeminal primary afferent neurons. 
3. Neurotrophic factors and neurotrophin receptors 
Neurotrophic factors or neurotrophins are a family of structurally and functionally related 
polypeptides that promote neuronal differentiation, survival and neurochemical plasticity 
during development by signaling via both a low-affinity p75 receptor and high-affinity 
transmembrane receptors belonging to the Trk proto-oncogene family. It has been proposed 
that neurotrophins and their receptors play an essential role in long-term neural trophics 
and trophic mechanisms during adult life, and may also regulate phenotypic expression. 
Recent advances in neuroscience have shown that in addition to their trophic support 
actions, neurotrophins share many functional properties with classical neurotransmitters as 
well and may function as neuromodulators in neuronal signaling.  
In fact, the concepts of neurotrophin-dependent survival, neurotrophin switching and 
neurotrophin co-operativity have largely arisen from works on the trigeminal system 
(Davies, 1997). Indeed, it is now well documented that developing trigeminal afferent 
neurons respond to all four known neurotropic factors, albeit in different capacities. 
Specifically, the localization of the nerve growth factor (NGF), brain-derived neurotrophin 
factor (BDNF), neurotrophin-3 (NT-3) and NT-4/5 has been demonstrated in discrete 
neuronal subsets of the human TG at an age ranging from 23 weeks of gestation to 
adulthood (Quartu et al., 1997). In early development, embryonic TG neurons depend for 
their survival on the action of the BDNF, NT-3 or NT-4/5 but not on NGF (Buchmann & 
Davies, 1993). Accordingly, within the developing TG neurotrophin receptor expression is 
high around the time of target innervation (Ernfors et al., 1992) and, moreover, two or more 
Trk receptor isoforms are co-expressed in embryonic rat TG neurons (Moshnyakov et al., 
1996). Similarly, MTN neurons display modality specific neurotrophin dependence in their 
development (Davies, 1997). For instance, during the earliest stages of neurogenesis the 
developing MTN neurons are transiently supported by BDNF and NT-3, but not by NGF 
(Copray & Liem, 1993; Davies et al., 1987). Recent work on the human MTN also suggests an 
active role for the glial cell line-derived neurotrophic factor and possibly other cognate 
ligands in the trophism from prenatal life to adulthood of the cells subserving the 
proprioceptive sensory transmission (Quartu et al., 2006). Studies on the neurotrophin 
receptor expression indicate the presence of p75 (Henry et al., 1993) and all the Trk receptor 
types within the adult (Yamuy et al., 2000) and developing MTN (Williams et al., 1995). 
Besides, most MTN neurons express multiple Trk isoforms (Jacobs & Miller, 1999). These 
results conclusively support the notion that MTN neurons are sensitive to the direct effects 
of more than one neurotrophin. Recent studies provide some of the initial evidence that the 
neurotrophin requirements of trigeminal primary afferent neurons are related to a specific 
sensory modality. For example, the high-affinity NGF receptor, TrkA, is considered a 
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marker for peptide-containing nociceptors. Interestingly, Trk receptors appear to be co-
expressed with SP and CGRP in a population of small trigeminal primary afferent neurons 
(Quartu et al., 1996). 
4. Trigeminal response to injury and neurochemical plasticity of trigeminal 
primary afferent neurons 
Research on putative neuromessengers in the trigeminal sensory system has reached 
another peak of interest over the last decade since it was shown that primary afferent 
neurons possess the ability to make adaptive changes in their transmitter phenotype in 
response to environmental cues (Table 2). It is now well known that injury to the peripheral 
trigeminal nerve results in nerve cell degeneration and that peripheral nerve damage evokes 
dynamic alterations in the levels of expressions of neurotrophins, neuropeptides and their 
receptors in the projection areas of injured axons, a phenomenon called chemical plasticity 
(Hökfelt et al., 1994). Indeed, after axotomy of the inferior alveolar nerve, there is a marked 
reduction in the total SP and CGRP expression in TG neurons (Elcock et al., 2001) and their 
release is largely enhanced by peripheral inflammation (Neubert et al., 2000). Conversely, 
the NPY and VIP levels are dramatically increased in axotomized TG neurons (Sasaki et al., 
1994; Fristad et al., 1998). It is generally presumed that neuropeptides repressed after 
axotomy participate normally in sensory transmission while those induced may function as 
neurotrophic factors involved in the response to injury and in axonal regeneration (Nielsch 
& Keen, 1989). The axonal signals induced in response to nerve injury activate several 
signaling pathways of genes in the neuronal cell bodies that may lead to two opposing 
outcomes: cell death or regenerative response. In effect, peripheral nerve injury causes the 
surviving neurons to shift their activity away from normal maintenance and 
neurotransmission toward a regenerative state (Navarro, 2009). It is thought that changes in 
gene expression after axonal injury are due to a blockage of NGF retrograde axonal flow 
from the periphery to the cell body. This may explain why both high (TrkA) and low (p75) 
affinity neurotrophin receptor transcripts in the TG neurons increase after tooth injury 
(Wheeler et al., 1998) 
As it can be inferred from Table 2, axotomy-induced alterations in the expression of 
neuroactive substances in MTN neurons include a long-lasting decrease (down-regulation) 
in the content of CaBPs, up-regulation of NO and some neurotrophins, and a de novo 
synthesis of certain neuropeptides, such as GAL, NPY and CGRP (see Lazarov, 2002, 2007, 
and references therein). A commonly shared view is that a characteristic of neuropeptides is 
the plasticity in their expression, reflecting the fact that release has to be compensated by de 
novo synthesis in the neuronal body (Navarro et al., 2007). It may be postulated that the 
newly synthesized neuropeptides can enhance MTN neuronal survival and neurite 
regeneration in the adaptive processes following nerve injury. Therefore, a peptide 
involvement in the proprioceptive function develops mainly in abnormal conditions. 
Navarro and co-workers (2007) also state that injured neurons respond by up-regulation of 
neurotrophins, either by autocrine or paracrine sources, and that additional exogenous 
supply of neurotrophic factors may further enhance the regenerative response of 
peripherally axotomized neurons. It should be noted that the survival of proprioceptors 
during the early postnatal period is probably dependent upon BDNF since its application to 
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the proximal stump of the transected masseteric nerve delays the loss of MTN neurons after 
the cut (Ichikawa et al., 2007). On the other hand, altered levels of CaBPs may be related to 
adequate cell body response since the sensitivity of damaged neurons to the intracellular  
 
Neuroactive 
substance 
Trigeminal 
ganglion 
Mesencephalic 
trigeminal 
nucleus 
Effect 
 Injury consequence  
Neurotransmitters    
NO Upregulation Upregulation Cell death or defenc 
Neuropeptides    
SP Downregulation   
CGRP Downregulation De novo 
synthesis 
Supportive role in 
NPY Upregulation De novo 
synthesis 
Cell protection 
GAL Upregulation De novo 
synthesis 
Cell regeneration 
PACAP Upregulation De novo 
synthesis 
Increase in 
neurotrophin 
responsiveness 
Increase in neurotrophin 
responsiveness 
Calcium-binding 
proteins 
   
Parvalbumin (PV)  Downregulation Downregulation Cell defence 
Calbindin D-28 
(CB)  
Downregulation Downregulation Cell survival 
    
Neurotrophic factors and their receptors  
NGF Upregulation Upregulation Peptide synthesis  induction 
Enhancement membrane 
   Enhancement of membrane 
potential oscillations  
TrkA Upregulation Upregulation Enhanced neuronal survival 
and maintenance 
BDNF  Upregulation Upregulation Cell protection 
Table 2. Summary of the injury-induced alterations in the expression of neuroactive 
substances and their effects on mammalian trigeminal primary afferent neurons 
calcium concentration is different from that of intact ones. A logical explanation for the 
reported down-regulation in CaBP expression may be the actual reduction of the MTN cell 
number following periphery axotomy (Ichikawa et al., 2007). This would be in line with the 
suggestion that persistently increased levels of NOS in mesencephalic trigeminal neurons 
may be involved in slowly progressive nerve cell death following nerve damage because 
they may lead to an augmented vulnerability of the neurons to calcium-mediated 
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neurotoxicity. Alternatively, it is reasonable to speculate that the possible endogenous 
production of NO might underlie a defense mechanism of the neurons against nerve injury 
and, thus, improve survival and active regeneration of MTN neurons. 
In summary, these findings provide compelling evidence that the content of the 
neurochemicals in both central and peripheral trigeminal primary afferent neurons is not 
static and their level may vary in case of marked changes in the environmental conditions, 
thus implying neuroplasticity as another major attribute of theirs. 
5. Clinical relevance 
Trigeminal primary afferent neurons have been the focus of intense research also because of 
their contribution to acute and chronic pain states, and the important role played by 
trigeminal nociceptive pathways in most clinically significant pain disorders. In response to 
trigeminal nerve activation, craniofacial pain symptoms can manifest as transient pain 
conditions as reported with toothaches and headaches, or can transform into more chronic 
pain conditions such as migraine, temporomandibular joint disorders or trigeminal 
neuralgia (Durham & Garrett, 2010). Apart from electrical activation, chemical activation of 
the trigeminal nerve leads to an afferent and efferent release of certain neuropeptides that 
facilitate peripheral inflammatory responses and causes activation of second-order neurons 
involved in pain transmission (Buzzi, 2001). Accumulating evidence suggests that CGRP 
and NO are involved in the underlying pathophysiology of all vascular headaches, the vast 
majority of which are associated with an inflammatory process. In particular, CGRP, a 
potent vasodilator and pro-inflammatory agent which is expressed by trigeminal 
nociceptors, has been identified as a key player in the pathomechanism of migraine 
headache (McCulloch et al., 1986). Clinical studies have also shown a clear association 
between the head pain and the release of CGRP, from the trigeminovascular system (for a 
review, see Edvinsson & Uddman, 2005). For example, during migraine attacks there is a 
marked increase in the plasma levels of CGRP and the administration of a recently 
developed CGRP blocker, BIBN4096BS, causes the headache to subside and the 
neuropeptide levels to normalize (Olesen et al., 2004). On the other hand, the efficacy of SER 
agonists for migraine therapy is known, and this amine, probably along with CGRP, has 
been hypothesized to be involved in trigeminal pain (Moskowitz et al., 1979) by activating 5-
HT1B, 5-HT1D (Bonaventure et al., 1998; Wotherspoon & Priestly, 2000) and 5-HT7 (Terrón et 
al., 2001; see also Classey et al., 2010) receptors. Indeed, the systemic administration of 
sumatriptan, the most-studied of the serotonergic drugs now collectively known as the 
triptans, lowers CGRP levels to nearly normal levels coincident with headache relief 
(Goadsby & Edvinsson, 1991). NO, an inflammatory mediator, is also currently thought of 
as a key molecule in migraine pain, possibly in concert with CGRP (Thomsen & Olesen, 
1996). Results from animal studies have provided evidence for the involvement of NO in 
sensitation and/or activation of the trigeminovascular system and repressed release of 
CGRP from trigeminal neurons in response to treatment with NO donors or application of 
the anti-migraine drug sumatriptan, which has affinity for 5-HT1B, 5-HT1D and 5-HT1F 
receptors (Bellamy et al., 2006). It seems likely that NO production and neuropeptide release 
are functionally linked in severe vascular headaches. Conversely, SP, which along with 
CGRP is the most definitely characterized peptide in the TG, is not released in the cranial 
blood flow in migraine suggesting that SP does not take part in vascular nociception in man 
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(Holthusen et al., 1997). It has recently been demonstrated that SP release in the TG is 
predominantly increased after orofacial inflammation (Neubert et al. 2000) and such a 
release may play an important role in determining the trigeminal inflammatory alloying 
concerning the temporomandibular joint disorder (Takeda et al., 2005). The authors point 
out that NK1 receptor antagonists may be useful as therapeutic agents to prevent the 
mechanical allodynia. P2X3 receptors may be another therapeutic target for treating 
temporomandibular joint disorder pain (Shinoda et al., 2005). 
Another common clinical concern regarding the trigeminal nerve is trigeminal neuralgia. 
Evidence for the role of SP and CGRP in trigeminal neuralgia pain is clearly apparent 
(Stoyanova & Lazarov, 2001). Inhibitory neurotransmitters, such as GABA, are thought to 
have a role in analgesia and many GABAergic drugs, acting through metabotropic GABAB 
receptors, are useful in the treatment of migraine and trigeminal neuralgia. With regard to 
the latter, a GABA analogue, gabapentin, has been reported to be effective in the 
management of migraine and trigeminal neuralgia, and also displays anti-nociceptive 
activity in various animal pain models. In addition, a selective GABAB receptor agonist, 
baclofen, has been shown to elicit pain relief and, thus, it might play a therapeutic role in the 
inhibition of nociceptive hypersensitivity in trigeminal neuralgia (Fromm, 1994). 
Clinically relevant is also pain, caused by a central or peripheral nerve lesion which is 
commonly termed neuropathic pain, and the concomitant neurogenic inflammation. 
Orofacial neuropathic pain, like anywhere in the body, may occur as a result of tissue 
damage and the activation of nociceptors, which transmit a noxious stimulus to the brain 
(Vickers & Cousins, 2000). The abnormal facial pain involves regeneration of damaged 
nerve fibers and may account for chemical changes in injured neuronal cell bodies. As 
mentioned above, a variety of neuropeptides, such as SP, CGRP, GAL and NPY, are up-
regulated following peripheral axotomy (see Table 2) and craniofacial muscle inflammation 
(Ambalavanar et al., 2006). Results from studies on animal pain models have suggested that 
NPY and its receptors are potential targets for treatment of pain, especially neuropathic pain 
(Silva et al., 2002). The efficacy of opioid receptor agonists in modulation of nociceptive 
inputs in a wide range of orofacial pain models, including neuropathic pain (Catheline et al., 
1998) and inflammatory pain (Ko et al., 1998) is also acknowledged. Given that NGF is 
responsible for the increased expression of SP and CGRP during neurogenic inflammation 
(Lundy & Linden, 2004), it is not much surprising that the systemic administration of anti-
NGF neutralizing antibodies prevents the up-regulation of neuropeptides in primary 
afferent neurons innervating the inflamed skin (Woolf et al., 1994). Changes in the injured 
neurons can also influence the ability of the surrounding glial cells to release 
neuromodulators such as NO and ATP, thus implicating satellite glial cells in the TG as a 
determinant of orofacial neuropathic pain. This fits well with the notion that the P2X3 
receptor is transiently up-regulated and anterogradely transported in trigeminal primary 
afferent neurons after neuropathic injury (Eriksson et al., 1998). Purinergic receptors on TG 
neurons are thus likely to be a legitimate target for therapeutic intervention in neuropathic 
pain and orofacial inflammation (Ambalavanar et al., 2005). Recent findings further 
demonstrate that masseter inflammation differentially modulates Glu receptor subunits and 
that the induced changes in them may contribute to functionally different aspects of 
craniofacial muscle pain processing under inflammatory conditions (Lee and Ro, 2007). 
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6. Concluding remarks 
Based on the information now available, it has become evident that miscellaneous 
transmitter candidates are associated with a subset of trigeminal primary afferent neurons 
and, besides, these are well-innervated by aminergic, peptidergic and nitrergic fibers of a 
probable extrinsic origin. The data also suggest that some classical neurotransmitters and 
neuropeptides not only mediate trans-synaptic information coding but can also act as long-
term morphogenetic signals and trophic factors. Progressive discovery of the multiplicity of 
chemical messengers, of coexistent transmitters (or transmitter candidates), their receptors 
and transducing mechanisms, and of local mechanisms for transmitter release, has 
reinforced the view that chemical coding in trigeminal primary afferent neurons, either 
peripherally or centrally, is multiple, heterogeneous, plastically varying and characterized 
by a wide spectrum of co-existing messenger substances. In line with similar morphological 
features and trophic factor requirements, as well as diverse central and peripheral targets, 
and physiological properties, we show that TG and MTN neurons have both similarities and 
differences in their neurochemical content. On the one hand, the most important similarity 
relates to the fact that both central and peripheral trigeminal primary afferent neurons 
express, indeed to a varying degree, classical transmitters and neuronal markers, such as 
calcium-binding proteins. On the other hand, the most marked spatial difference is the 
presence of certain neuropeptides in the TG cell bodies and their absence in the MTN 
neuronal somata under normal conditions. As argued before, we believe that the differently 
fated embryonic migration, synaptogenesis, and peripheral and central target field 
innervation can possibly affect the individual neurochemical phenotypes of trigeminal 
primary afferent neurons. 
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